Chirag Khatiwala
Vice President - Process Development & Manufacturing Obsidian Therapeutics
Biotechnology executive with 20 years of experience driving innovation, regulatory success, and commercialization of advanced therapies. Proven track record leading global CMC, MSAT, and GMP operations across cell therapy, viral vectors, and biologics. Recognized for building high-performing teams, securing IND/BLA approvals, and delivering multi-million-dollar process improvements that accelerate time-to-market and ensure patient access. An effective leader dedicated to empowering and developing personnel, ensuring a culture of growth and excellence.
Seminars
Wednesday 25th February 2026
Roundtable Discussion: Is Bigger Always Better? Defining the Right Scale to Effectively Balance Yield, Safety & Cost
11:30 am
- Contrasting scalability limitations across vector types and how physical constraints shape commercial strategy
- Discussing trade-offs between driving higher titres versus maintaining potency and how these challenges can differ across vector classes
- Deciding between ‘scaling up’ and ‘scaling out’ and how this can be affected by modality, indication, and regulatory expectation
